Your session is about to expire
← Back to Search
Perampanel for Amyotrophic Lateral Sclerosis
Study Summary
This trial is testing the safety and preliminary efficacy of perampanel in ALS patients. Perampanel is an oral medication that is approved by the FDA for treatment of seizures in patients with epilepsy. This study will consist of two treatments arms: perampanel and matching placebo randomized at a 1:1 ratio. Subjects will receive medication for 9 months.
- ALS (Amyotrophic Lateral Sclerosis)
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 4 trial • 54 Patients • NCT03288129Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Who is considered a suitable candidate for this investigation?
"For individuals to be eligible for this study, they must have been diagnosed with amyotrophic lateral sclerosis and between 18-80 years of age. Currently, the team is looking to recruit around 60 volunteers."
Are there any extant investigations that include Perampanel as a component?
"Presently, 11 clinical trials are underway to evaluate the efficacy of perampanel. Of these active studies, none have reached Phase 3 yet. Primarily based out of New york City, there are 93 locations offering this therapy across the United States."
Has a similar experiment been undertaken before?
"Currently, 11 active trials for the drug Perampanel are being conducted in 51 cities spanning 9 countries. These tests commenced in 2017 under the auspices of Eisai Inc., and included 60 participants who completed their N/A stage with success. Since then, a further 222 experiments have been concluded."
Are the parameters of this research open to those above 35 years old?
"To qualify for this clinical trial, patients must be aged between 18 and 80. An additional 47 studies are available for minors and 402 extra trials have been created to assess elderly populations."
Are interested individuals currently being accepted into this trial?
"According to clinicaltrials.gov, this medical research is currently recruiting suitable candidates and was first posted on December 1st 2017 with the latest update occurring on April 28th 2021."
How many test subjects are enrolled in this experiment?
"Affirmative. According to the information on clinicaltrials.gov, this scientific investigation is open for enrolment and was initially published on December 1st 2017 with its last update posted in late April 2021. The study requires 60 volunteers from one medical centre."
Share this study with friends
Copy Link
Messenger